| CPC A61B 5/25 (2021.01) [A61B 5/6801 (2013.01); H03F 1/10 (2013.01); H03F 1/26 (2013.01); H03F 3/005 (2013.01); H03F 3/087 (2013.01); H03F 3/45475 (2013.01); A61B 5/053 (2013.01); A61B 5/369 (2021.01); A61B 5/389 (2021.01); A61B 5/6823 (2013.01); A61B 5/7203 (2013.01); A61B 2562/0209 (2013.01); H03F 2200/261 (2013.01); H03F 2203/45551 (2013.01)] | 18 Claims |

|
1. A method for detecting lead-off detection while measuring a biopotential of a patient comprising, the method comprising:
providing a first lead electrode, second lead electrode, and third lead electrode, the first, second and third lead electrodes configured to make direct electrical contact with a skin of the patient;
electrically connecting a proximal end of a first high resistance resistor to the first lead electrode;
electrically connecting a proximal end of a second high resistance resistor to the second lead electrode;
applying a current to the third lead electrode;
DC coupling both electrical pathways from the first and second lead electrodes to a current amplifier;
measuring an average current in a given time interval from an output of the current amplifier by charging a capacitor disposed between distal ends of the first and second high resistance resistors; and
determining lead-off detection of at least one of the first, second and third lead electrodes at least based on a measured output of the current amplifier.
|